Scientific Programme
 |
12:45 - 14:15 Poster Session 5 - BPH: Basic research and medical therapy I
| 92: The identification of a novel stromal stem/progenitor cell phenotype in the human adult prostate J.A. Ceder, Malmö (SE) |
| 93: Human benign prostatic hyperplasia cells as inducers and targets of chronic autoimmune inflammation G.P. Penna, Milano (IT) |
| 94: Identification of the urogenital infection pathogens in genital excreta and prostatic tissue in patients with benign prostatic hyperplasia V.S. Gritsay, Kyiv (UA) |
| 95: Extracellular matrix modifications in the hyperplastic prostate as compared with the transitional zone of the normal gland L.E.M Cardoso, Rio de Janeiro (BR) |
| 97: Expression of cyclic AMP-dependent protein kinase-I isoforms in the human prostate: Relation to smooth muscle alpha-actin and PDE4 E. Waldkirch, Hanover (DE) |
| 98: Combination of alfuzosin and tadalafil exerts additive relaxant effect on human prostate F. Giuliano, Garches (FR) |
| 99: Improvements in patient-reported quality of life with dutasteride, tamsulosin and the combination: 2-year results from the Combination of Avodart and Tamsulosin (CombAT) trial J. Barkin, Toronto (CA) |
| 102: Predictors of success of a trial without catheter: Results of a cross-sectional survey in 3,785 BPH men with acute urinary retention J.M. Fitzpatrick, Dublin (IE) |
| 103: Change of prostate volume after discontinuation of 5-alpha reductase inhibitor in patients with benign prostate hyperplasia: A prospective study Y.B. Jeong, Jeonju (KR) |